Back
Heron Therapeutics Stock Price Chart
Sponsored
HRTX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
21
HRTX
Heron Therapeutics
Last Price:
2.06
Seasonality Move:
-8.85%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is relatively stagnant and HRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Heron Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.91 | Buy |
20-day SMA: | 1.88 | Buy |
50-day SMA: | 2.34 | Sell |
200-day SMA: | 2.59 | Sell |
8-day EMA: | 1.94 | Buy |
20-day EMA: | 1.95 | Buy |
50-day EMA: | 2.24 | Sell |
200-day EMA: | 2.47 | Sell |
Heron Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 53.39 | Buy |
Chaikin Money Flow: | 2662651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 1.97) | Buy |
Bollinger Bands (100): | (2.12 - 3.44) | Sell |
Heron Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.06 while HRTX 8-day simple moving average is 1.91, which is a Buy signal.
- The stock price of HRTX is 2.06 while Heron Therapeutics 20-day SMA is 1.88, which makes it a Buy.
- Heron Therapeutics 50-day simple moving average is 2.34 while HRTX share price is 2.06, making it a Sell technically.
- HRTX stock price is 2.06 and Heron Therapeutics 200-day simple moving average is 2.59, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
21
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $2.06. The Score for HRTX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
312.44M
Price in USD:
2.06
Share Volume:
2.66M
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
0.50
Sell
21
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 2.06 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.06 while HRTX 8-day exponential moving average is 1.94, which is a Buy signal.
- The stock price of HRTX is 2.06 while Heron Therapeutics 20-day EMA is 1.95, which makes it a Buy.
- Heron Therapeutics 50-day exponential moving average is 2.24 while HRTX share price is 2.06, making it a Sell technically.
- HRTX stock price is 2.06 and Heron Therapeutics 200-day simple moving average is 2.47, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Heron Therapeutics is a Sell
- Heron Therapeutics Relative Strength Index (RSI) is 53.39, which suggest Heron Therapeutics is overbought
- The Bollinger Bands (25) for Heron Therapeutics is (1.81 - 1.97), which suggest Heron Therapeutics is a Sell
- The Bollinger Bands (100) for Heron Therapeutics is (2.12 - 3.44), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.